High levels of methylation of the KEAP1 gene promoter have been observed in human CRC cell lines and tumour samples, leading to lower levels of KEAP1 mRNA, increased NRF2 protein and over-expression of its target genes [267,270]. This evidence concerns the gene NFE2L2 and neoplasm.